Infectious Diseases News and Research

RSS

Fred Hutch aims to prevent and find cures for cancers caused by infectious agents

Fred Hutchinson Cancer Research Center is launching a new integrated research center to prevent and find cures for cancers caused by infectious agents.

10 Aug 2017

Researchers develop rapid test for Zika virus diagnosis

Washington University in St. Louis researchers have developed a test that quickly detects the presence of Zika virus in blood.

10 Aug 2017

Study shows sustained impact and effectiveness of rotavirus vaccine program

Following the introduction of routine childhood vaccination against rotavirus, a common cause of diarrheal illness, more than 380,000 children avoided hospitalization for diarrhea from 2008 to 2013 in the U.S., thus saving an estimated $1.2 billion in direct medical costs.

10 Aug 2017

Cholera vaccines provide substantial protection for adults but less effective for children, review shows

A new review of the research literature led by researchers at the Johns Hopkins Bloomberg School of Public Health shows that cholera vaccines provide substantial protection for adults but provide significantly less protection for children under age 5, a population particularly at risk for dying from this diarrheal disease.

9 Aug 2017

ASU Biodesign researchers develop more potent, safer plant-based Zika vaccine

The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the Americas. It struck great fear in pregnant women, as babies born with severe brain birth defects quickly overburdened hospitals and public health care systems.

9 Aug 2017

High-frequency alternating magnetic fields can help destroy bacterial biofilms

A short exposure to an alternating magnetic field might someday replace multiple surgeries and weeks of IV antibiotics as treatment for stubborn infections on artificial joints, new research suggests.

9 Aug 2017

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.

4 Aug 2017

New online healthcare platform iDoc enables patients to book consultations with GPs anytime

Online digital healthcare provider iDoc, launches, with the aim of transforming the way patients access and interact with GPs and Paediatricians, nationally. Part of the Fidelity Health Group, iDoc offers patients the ability to have a GP appointment at a time and in a way, that suits them.

4 Aug 2017

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.

3 Aug 2017

Injectable ART may have same effectiveness as standard oral treatments

Antiretroviral therapy (ART) intramuscularly administered may have the same effectiveness as current oral treatments.

3 Aug 2017

When wounds won’t heal, therapies spread — to the tune of $5 billion

Carol Emanuele beat cancer. But for the past two years, she has been fighting her toughest battle yet. She has an open wound on the bottom of her foot that leaves her unable to walk and prone to deadly infection.

3 Aug 2017

Ebola virus RNA can persist in semen of survivors two years after infection, researchers say

Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found.

2 Aug 2017

InDevR gets NIAID support for verification, validation studies on new potency test for influenza viruses

InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.

2 Aug 2017

Study shows how climate change affects Europe's most dangerous pathogens

The impact of climate change on the emergence and spread of infectious diseases could be greater than previously thought, according to new research by the University of Liverpool.

2 Aug 2017

Researchers identify new methods that could improve treatment for infectious diseases

Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

2 Aug 2017

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.

1 Aug 2017

Biomedical researcher wins $1.9 million federal grant to develop enhanced influenza vaccines

Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has renewed a four-year, $1.9 million federal grant to develop influenza vaccines that offer enhanced protection against a broad range of influenza virus strains.

31 Jul 2017

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Findings presented at the American Society for Microbiology's ASM Microbe conference show that the ultra-sensitive Clostridium difficile toxin A/B assay in development for use on the Sgx Clarity™ system offers excellent sensitivity and may be a critical tool for improving the diagnosis of this life-threatening infection.

29 Jul 2017

Scientists developing new tool to help physicians reduce unnecessary use of antibiotics

Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance.

28 Jul 2017

Roche receives FDA clearance for new Troponin T test to detect patients with suspected heart attack

Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack.

27 Jul 2017

Infectious Diseases News and Research

Fred Hutch aims to prevent and find cures for cancers caused by infectious agents

Researchers develop rapid test for Zika virus diagnosis

Study shows sustained impact and effectiveness of rotavirus vaccine program

Cholera vaccines provide substantial protection for adults but less effective for children, review shows

ASU Biodesign researchers develop more potent, safer plant-based Zika vaccine

High-frequency alternating magnetic fields can help destroy bacterial biofilms

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

New online healthcare platform iDoc enables patients to book consultations with GPs anytime

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

Injectable ART may have same effectiveness as standard oral treatments

When wounds won’t heal, therapies spread — to the tune of $5 billion

Ebola virus RNA can persist in semen of survivors two years after infection, researchers say

InDevR gets NIAID support for verification, validation studies on new potency test for influenza viruses

Study shows how climate change affects Europe's most dangerous pathogens

Researchers identify new methods that could improve treatment for infectious diseases

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

Biomedical researcher wins $1.9 million federal grant to develop enhanced influenza vaccines

Ultra-sensitive C. difficile toxin assay may be critical tool for improving diagnosis of infectious disease

Scientists developing new tool to help physicians reduce unnecessary use of antibiotics

Roche receives FDA clearance for new Troponin T test to detect patients with suspected heart attack

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News